A randomized, blinded, phase 2 dose-ranging study of BMS

  • Dudek, Arkadiusz Z (PI)

Project: Research project

Project Details

Description

A randomized, blinded, phase 2 dose-ranging study of BMS-936558 in subjects with progressive advanced/metastatic clear cell renal carcinoma who have received prior anti-angiogenic therapy
StatusFinished
Effective start/end date3/21/118/31/15

Funding

  • BRISTOL-MYERS SQUIBB PHARM RES

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.